Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Select Medical Holdings (SEM) Cost of Revenue (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Cost of Revenue for 9 consecutive years, with $1.2 billion as the latest value for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 6.26% year-over-year to $1.2 billion; the TTM value through Mar 2026 reached $4.9 billion, up 6.33%, while the annual FY2025 figure was $4.8 billion, 5.93% up from the prior year.
  • Cost of Revenue hit $1.2 billion in Q1 2026 for Select Medical Holdings, roughly flat from $1.3 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.4 billion in Q1 2022 and bottomed at $16.3 million in Q4 2022.
  • Average Cost of Revenue over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2025.
  • Year-over-year, Cost of Revenue tumbled 98.84% in 2022 and then skyrocketed 6485.7% in 2023.
  • Select Medical Holdings' Cost of Revenue stood at $16.3 million in 2022, then surged by 6485.7% to $1.1 billion in 2023, then grew by 9.41% to $1.2 billion in 2024, then rose by 6.44% to $1.3 billion in 2025, then dropped by 0.38% to $1.2 billion in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $1.2 billion, $1.3 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.